PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1985 August; 78(8): 623–627.
PMCID: PMC1289832

Prevention of recurrent spontaneous abortions by leukocyte transfusions.

Abstract

One hundred and thirty-nine couples referred because of recurrent abortions with no obvious cause were assessed for genetic similarity using the HLA major histocompatibility system. Comparison with 103 fertile control couples demonstrated that a much higher proportion of couples in the abortion group shared two or more HLA antigens. Using this criterion, 44 wives out of the 139 couples referred, when compared with a child-bearing group, appeared to share a greater than expected number of histocompatibility antigens and were therefore considered suitable for treatment. Twenty-eight wives have received treatment with white cell infusions from erythrocyte-compatible donors and so far they have delivered 17 babies plus 2 second babies. Another 3 wives are pregnant beyond their previous dates for abortions (1 first and 2 second pregnancies). There have been 5 failures (4 first pregnancy and 1 second pregnancy); one of these was treated a second time and has now successfully delivered. Seven couples are awaiting conception. Of the patients who have become pregnant, 81.5% have had successful deliveries. No adverse transfusion reactions have been observed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (734K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bodmer WF. HLA structure and function: a contemporary view. Tissue Antigens. 1981 Jan;17(1):9–20. [PubMed]
  • Chaouat G, Voisin GA. Regulatory T-cell subpopulations in pregnancy. II. Evidence for suppressive activity of the late phase of MLR. Immunology. 1980 Feb;39(2):239–248. [PubMed]
  • Faulk WP, Hsi BL, McIntyre JA, Yeh CJ, Mucchielli A. Antigens of human extra-embryonic membranes. J Reprod Fertil Suppl. 1982 Nov;31:181–199. [PubMed]
  • Faulk WP, McIntyre JA. Trophoblast survival. Transplantation. 1981 Jul;32(1):1–5. [PubMed]
  • Faulk WP, McIntyre JA. Immunological studies of human trophoblast: markers, subsets and functions. Immunol Rev. 1983;75:139–175. [PubMed]
  • Faulk WP, Temple A. Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae. Nature. 1976 Aug 26;262(5571):799–802. [PubMed]
  • Gill TJ., 3rd Immunogenetics of spontaneous abortions in humans. Transplantation. 1983 Jan;35(1):1–6. [PubMed]
  • Jeannet M, Werner C, Ramirez E, Vassalli P, Faulk WP. Anti-HLA, anti-human "Ia-like" and MLC blocking activity of human placental IgG. Transplant Proc. 1977 Jun;9(2):1417–1422. [PubMed]
  • Komlos L, Halbrecht I. Repeated abortions and histocompatibility antigens. Can HLA antigen restricted gene dose effects influence the feto-maternal relationship? Med Hypotheses. 1979 Aug;5(8):901–908. [PubMed]
  • McIntyre JA, Faulk WP. HLA and the generation of diversity in human pregnancy. Placenta Suppl. 1982;4:1–11. [PubMed]
  • McIntyre JA, Faulk WP. Allotypic trophoblast-lymphocyte cross-reactive (TLX) cell surface antigens. Hum Immunol. 1982 Feb;4(1):27–35. [PubMed]
  • McIntyre JA, Faulk WP. Recurrent spontaneous abortion in human pregnancy: results of immunogenetical, cellular, and humoral studies. Am J Reprod Immunol. 1983 Dec;4(4):165–170. [PubMed]
  • McIntyre JA, Faulk WP. Histocompatibility and recurrent abortion. Fertil Steril. 1984 Apr;41(4):653–654. [PubMed]
  • McIntyre JA, Faulk WP, Verhulst SJ, Colliver JA. Human trophoblast-lymphocyte cross-reactive (TLX) antigens define a new alloantigen system. Science. 1983 Dec 9;222(4628):1135–1137. [PubMed]
  • McIntyre JA, McConnachie PR, Taylor CG, Faulk WP. Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertil Steril. 1984 Dec;42(6):849–855. [PubMed]
  • Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A. Fetal loss after implantation. A prospective study. Lancet. 1980 Sep 13;2(8194):554–556. [PubMed]
  • Rock JA, Zacur HA. The clinical management of repeated early pregnancy wastage. Fertil Steril. 1983 Feb;39(2):123–140. [PubMed]
  • Rocklin RE, Kitzmiller JL, Carpenter CB, Garovoy MR, David JR. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med. 1976 Nov 25;295(22):1209–1213. [PubMed]
  • Sunderland CA, Naiem M, Mason DY, Redman CW, Stirrat GM. The expression of major histocompatibility antigens by human chorionic villi. J Reprod Immunol. 1981 Dec;3(6):323–331. [PubMed]
  • Taylor C, Faulk WP. Prevention of recurrent abortion with leucocyte transfusions. Lancet. 1981 Jul 11;2(8237):68–70. [PubMed]
  • Unander AM, Olding LB. Habitual abortion: parental sharing of HLA antigens, absence of maternal blocking antibody, and suppression of maternal lymphocytes. Am J Reprod Immunol. 1983 Dec;4(4):171–178. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press